annual working capital:
$599.67M-$18.02M(-2.92%)Summary
- As of today (September 8, 2025), XENE annual working capital is $599.67 million, with the most recent change of -$18.02 million (-2.92%) on December 31, 2024.
- During the last 3 years, XENE annual working capital has risen by +$54.98 million (+10.09%).
- XENE annual working capital is now -2.92% below its all-time high of $617.69 million, reached on December 31, 2023.
Performance
XENE Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$467.20M-$66.30M(-12.43%)Summary
- As of today (September 8, 2025), XENE quarterly working capital is $467.20 million, with the most recent change of -$66.30 million (-12.43%) on June 1, 2025.
- Over the past year, XENE quarterly working capital has dropped by -$229.60 million (-32.95%).
- XENE quarterly working capital is now -40.18% below its all-time high of $781.07 million, reached on June 30, 2022.
Performance
XENE quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
XENE Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.9% | -33.0% |
| 3 y3 years | +10.1% | -40.2% |
| 5 y5 years | +490.9% | +151.3% |
XENE Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.9% | +10.1% | -40.2% | at low |
| 5 y | 5-year | -2.9% | +490.9% | -40.2% | +179.8% |
| alltime | all time | -2.9% | +1793.8% | -40.2% | +1570.0% |
XENE Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $467.20M(-12.4%) |
| Mar 2025 | - | $533.51M(-11.0%) |
| Dec 2024 | $599.67M(-2.9%) | $599.67M(-4.8%) |
| Sep 2024 | - | $629.94M(-9.6%) |
| Jun 2024 | - | $696.80M(+1.7%) |
| Mar 2024 | - | $684.98M(+10.9%) |
| Dec 2023 | $617.69M(+6.9%) | $617.69M(+22.0%) |
| Sep 2023 | - | $506.26M(-2.0%) |
| Jun 2023 | - | $516.46M(+1.1%) |
| Mar 2023 | - | $510.86M(-11.6%) |
| Dec 2022 | $577.60M(+6.0%) | $577.60M(-8.8%) |
| Sep 2022 | - | $633.64M(-18.9%) |
| Jun 2022 | - | $781.07M(+45.3%) |
| Mar 2022 | - | $537.63M(-1.3%) |
| Dec 2021 | $544.70M(+226.2%) | $544.70M(+123.7%) |
| Sep 2021 | - | $243.46M(-3.3%) |
| Jun 2021 | - | $251.77M(-7.4%) |
| Mar 2021 | - | $271.77M(+62.7%) |
| Dec 2020 | $167.00M(+64.6%) | $167.00M(-6.1%) |
| Sep 2020 | - | $177.89M(-4.3%) |
| Jun 2020 | - | $185.96M(+0.3%) |
| Mar 2020 | - | $185.35M(+82.6%) |
| Dec 2019 | $101.49M | $101.49M(+19.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $84.78M(-9.8%) |
| Jun 2019 | - | $94.00M(-11.0%) |
| Mar 2019 | - | $105.67M(-9.9%) |
| Dec 2018 | $117.21M(+187.7%) | $117.32M(-6.2%) |
| Sep 2018 | - | $125.08M(+104.2%) |
| Jun 2018 | - | $61.26M(+86.3%) |
| Mar 2018 | - | $32.87M(-19.3%) |
| Dec 2017 | $40.74M(-34.5%) | $40.74M(-2.8%) |
| Sep 2017 | - | $41.93M(-14.2%) |
| Jun 2017 | - | $48.86M(-12.0%) |
| Mar 2017 | - | $55.55M(-10.6%) |
| Dec 2016 | $62.16M(+7.0%) | $62.16M(-7.7%) |
| Sep 2016 | - | $67.37M(+33.5%) |
| Jun 2016 | - | $50.46M(-8.9%) |
| Mar 2016 | - | $55.40M(-4.6%) |
| Dec 2015 | $58.08M(-17.8%) | $58.08M(-4.4%) |
| Sep 2015 | - | $60.78M(-2.5%) |
| Jun 2015 | - | $62.34M(-6.7%) |
| Mar 2015 | - | $66.80M(-5.5%) |
| Dec 2014 | $70.66M(+123.1%) | $70.66M(+121.3%) |
| Sep 2014 | - | $31.93M(+14.1%) |
| Jun 2014 | - | $27.98M(-11.6%) |
| Dec 2013 | $31.67M(-23.7%) | $31.67M |
| Dec 2012 | $41.51M | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual working capital?
- What is the all time high annual working capital for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual working capital year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly working capital?
- What is the all time high quarterly working capital for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly working capital year-on-year change?
What is Xenon Pharmaceuticals Inc. annual working capital?
The current annual working capital of XENE is $599.67M
What is the all time high annual working capital for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual working capital is $617.69M
What is Xenon Pharmaceuticals Inc. annual working capital year-on-year change?
Over the past year, XENE annual working capital has changed by -$18.02M (-2.92%)
What is Xenon Pharmaceuticals Inc. quarterly working capital?
The current quarterly working capital of XENE is $467.20M
What is the all time high quarterly working capital for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly working capital is $781.07M
What is Xenon Pharmaceuticals Inc. quarterly working capital year-on-year change?
Over the past year, XENE quarterly working capital has changed by -$229.60M (-32.95%)